Pulse Biosciences (PLSE) Operating Leases (2019 - 2025)

Pulse Biosciences' Operating Leases history runs 7 years deep, the most recent figure standing at $6.0 million for Q4 2025.

• In Q4 2025, Operating Leases fell 20.99% year-over-year to $6.0 million; the TTM figure through Dec 2025 stood at $6.0 million (down 20.99% YoY), while the FY2025 annual figure was $6.0 million, down 20.99% from the prior year.
• Operating Leases was $6.0 million for Q4 2025 at Pulse Biosciences, down from $6.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $10.6 million in Q1 2021 to a low of $6.0 million in Q4 2025.
• Historically, Operating Leases has averaged $8.7 million across 5 years, with a median of $9.1 million in 2022.
• Biggest YoY gain for Operating Leases was 58.92% in 2021; the steepest drop was 25.23% in 2021.
• A 5-year view of Operating Leases shows it stood at $8.1 million in 2021, then increased by 13.08% to $9.1 million in 2022, then changed by 0.0% to $9.1 million in 2023, then retreated by 17.51% to $7.5 million in 2024, then decreased by 20.99% to $6.0 million in 2025.
• The last three Operating Leases figures came in at $6.0 million (Q4 2025), $6.4 million (Q3 2025), and $6.8 million (Q2 2025), per Business Quant data.